Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Centessa Pharmaceuticals

    NASDAQ: CNTA · Real-Time Price · USD
    13.07
    -0.36 (-2.68%)
    At close: Jun 26, 2025, 3:59 PM
    13.04
    -0.23%
    After-hours: Jun 26, 2025, 04:04 PM EDT

    Centessa Pharmaceuticals Statistics

    Share Statistics

    Centessa Pharmaceuticals has 133.55M shares outstanding. The number of shares has increased by 32% in one year.

    Shares Outstanding

    n/a
    		 133.55M

    Shares Change (YoY)

    n/a
    		 32%

    Shares Change (QoQ)

    n/a
    		 0.74%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 84.74M

    Failed to Deliver (FTD) Shares

    n/a
    		 992

    FTD / Avg. Volume

    n/a
    		 0.1%

    Short Selling Information

    The latest short interest is 5.26M, so 3.94% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.26M

    Short % of Shares Out

    n/a
    		 3.94%

    Short % of Float

    n/a
    		 4.64%

    Short Ratio (days to cover)

    n/a
    		 5.93

    Valuation Ratios

    The PE ratio is -8.13 and the forward PE ratio is -9.09. Centessa Pharmaceuticals's PEG ratio is -0.26.

    PE Ratio

    n/a
    		 -8.13

    Forward PE

    n/a
    		 -9.09

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 4.4

    PB Ratio

    n/a
    		 4.78

    P/FCF Ratio

    n/a
    		 -13.49

    PEG Ratio

    n/a
    		 -0.26
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Centessa Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 9.25, with a Debt / Equity ratio of 0.29.

    Current Ratio

    n/a
    		 9.25

    Quick Ratio

    n/a
    		 9.25

    Debt / Equity

    n/a
    		 0.29

    Debt / EBITDA

    n/a
    		 -0.53

    Debt / FCF

    n/a
    		 -0.83

    Interest Coverage

    n/a
    		 -19.92

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,061,779.22

    Employee Count

    n/a
    		 77

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 2.84M

    Effective Tax Rate

    n/a
    		 -1.22%

    Stock Price Statistics

    The stock price has increased by 45.55% in the last 52 weeks. The beta is 1.49, so Centessa Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.49

    52-Week Price Change

    n/a
    		 45.55%

    50-Day Moving Average

    n/a
    		 12.78

    200-Day Moving Average

    n/a
    		 15.26

    Relative Strength Index (RSI)

    n/a
    		 52.14

    Average Volume (20 Days)

    n/a
    		 960,745

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -942K

    Operating Income

    n/a
    		 -201.06M

    Net Income

    n/a
    		 -235.76M

    EBITDA

    n/a
    		 -221.97M

    EBIT

    n/a
    		 -222.92M

    Earnings Per Share (EPS)

    n/a
    		 -2.06
    Full Income Statement

    Balance Sheet

    The company has 383.22M in cash and 117.23M in debt, giving a net cash position of 266M.

    Cash & Cash Equivalents

    n/a
    		 383.22M

    Total Debt

    n/a
    		 117.23M

    Net Cash

    n/a
    		 266M

    Retained Earnings

    n/a
    		 -988.7M

    Total Assets

    n/a
    		 527.85M

    Working Capital

    n/a
    		 323.52M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -142.06M and capital expenditures -34K, giving a free cash flow of -142.09M.

    Operating Cash Flow

    n/a
    		 -142.06M

    Capital Expenditures

    n/a
    		 -34K

    Free Cash Flow

    n/a
    		 -142.09M

    FCF Per Share

    n/a
    		 -1.24
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CNTA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CNTA is $31.5, which is 141% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $31.5

    Price Target Difference

    n/a
    		 141%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 10
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 4.01

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist